These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24423476)

  • 61. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
    Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
    Ann Vasc Surg; 2020 Jul; 66():595-600. PubMed ID: 31863948
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
    Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
    J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.
    Bausback Y; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
    J Endovasc Ther; 2017 Aug; 24(4):459-467. PubMed ID: 28558502
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.
    Teymen B; Akturk S; Akturk U; Tdjani M
    Vascular; 2018 Feb; 26(1):54-61. PubMed ID: 28708023
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Three year results of endovascular therapy with a new generation nitinol stent for femoro-popliteal artery lesions - a single-center outcome analysis of a subcohort of MISAGO 2 study.
    Kralj I; Boos I; Müller-Bühl U
    Vasa; 2013 Sep; 42(5):340-9. PubMed ID: 23989069
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
    Cassese S; Wolf F; Ingwersen M; Kinstner CM; Fusaro M; Ndrepepa G; Ibrahim T; Ott I; Lammer J; Krankenberg H; Fusaro M
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e007055. PubMed ID: 30562083
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Local Ultrasound to Enhance Paclitaxel Delivery After Femoral-Popliteal Treatment in Critical Limb Ischemia: The PACUS Trial.
    Gandini R; Del Giudice C
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2147-2153. PubMed ID: 27765310
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DETOUR2 trial outcomes demonstrate clinical utility of percutaneous transmural bypass for the treatment of long segment, complex femoropopliteal disease.
    Lyden SP; Soukas PA; De A; Tedder B; Bowman J; Mustapha JA; Armstrong EJ;
    J Vasc Surg; 2024 Jun; 79(6):1420-1427.e2. PubMed ID: 38367850
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
    Zeller T; Dake MD; Tepe G; Brechtel K; Noory E; Beschorner U; Kultgen PL; Rastan A
    JACC Cardiovasc Interv; 2013 Mar; 6(3):274-81. PubMed ID: 23517839
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute Outcomes With a Novel Plaque Modification System in Real-World Femoropopliteal Lesions.
    Zeller T; Lopez L; Pigott JP
    J Endovasc Ther; 2019 Jun; 26(3):333-341. PubMed ID: 31106694
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty.
    Bosiers M; Scheinert D; Hendriks JM; Wissgott C; Peeters P; Zeller T; Brodmann M; Staffa R;
    J Vasc Surg; 2016 Jul; 64(1):109-16. PubMed ID: 27139789
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of Atherectomy to Balloon Angioplasty and Stenting for Isolated Femoropopliteal Revascularization.
    Bai H; Fereydooni A; Zhuo H; Zhang Y; Tonnessen BH; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2020 Nov; 69():261-273. PubMed ID: 32512112
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions.
    Baril DT; Marone LK; Kim J; Go MR; Chaer RA; Rhee RY
    J Vasc Surg; 2008 Sep; 48(3):627-33. PubMed ID: 18727966
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Twelve-month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries.
    Piorkowski M; Freitas B; Steiner S; Botsios S; Bausback Y; Scheinert D; Schmidt A
    J Cardiovasc Surg (Torino); 2015 Feb; 56(1):89-95. PubMed ID: 25410147
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study.
    Schroeder H; Meyer DR; Lux B; Ruecker F; Martorana M; Duda S
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):278-86. PubMed ID: 25708850
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary stenting of the superficial femoral and popliteal artery.
    Dearing DD; Patel KR; Compoginis JM; Kamel MA; Weaver FA; Katz SG
    J Vasc Surg; 2009 Sep; 50(3):542-7. PubMed ID: 19540706
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Comparison of Clinical Outcomes for Diabetic and Nondiabetic Patients Following Directional Atherectomy in the DEFINITIVE LE Claudicant Cohort.
    Garcia LA; Jaff MR; Rocha-Singh KJ; Zeller T; Bosarge C; Kamat S; McKinsey JF
    J Endovasc Ther; 2015 Oct; 22(5):701-11. PubMed ID: 26250748
    [TBL] [Abstract][Full Text] [Related]  

  • 78. One-year results of drug-coated balloons for long and occlusive Femoropopliteal artery disease: a single-arm trial.
    Lai Z; Zhang X; Shao J; Li K; Fang L; Xu L; Yu X; Wang J; Liu X; Lei J; Liu B
    BMC Cardiovasc Disord; 2020 Feb; 20(1):65. PubMed ID: 32028896
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early outcome and intermediate follow-up of vascular stents in the femoral and popliteal arteries without long-term anticoagulation.
    White GH; Liew SC; Waugh RC; Stephen MS; Harris JP; Kidd J; Sachinwalla T; Yu W; May J
    J Vasc Surg; 1995 Feb; 21(2):270-9; discussion 279-81. PubMed ID: 7853600
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Endovascular treatment for symptomatic stent failures in long-segment chronic total occlusion of femoropopliteal arteries.
    Yang X; Lu X; Li W; Huang Y; Huang X; Lu M; Jiang M
    J Vasc Surg; 2014 Aug; 60(2):362-8. PubMed ID: 24680242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.